BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38473941)

  • 1. Combined
    Montoro-Jiménez I; Granda-Díaz R; Menéndez ST; Prieto-Fernández L; Otero-Rosales M; Álvarez-González M; García-de-la-Fuente V; Rodríguez A; Rodrigo JP; Álvarez-Teijeiro S; García-Pedrero JM; Hermida-Prado F
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions.
    Granda-Díaz R; Menéndez ST; Pedregal Mallo D; Hermida-Prado F; Rodríguez R; Suárez-Fernández L; Vallina A; Sánchez-Canteli M; Rodríguez A; Fernández-García MS; Rodrigo JP; García-Pedrero JM
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30823625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer.
    McCaughan F; Pole JC; Bankier AT; Konfortov BA; Carroll B; Falzon M; Rabbitts TH; George PJ; Dear PH; Rabbitts PH
    Am J Respir Crit Care Med; 2010 Jul; 182(1):83-91. PubMed ID: 20299530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1.
    Schaefer T; Ramadoss A; Leu S; Tintignac L; Tostado C; Bink A; Schürch C; Müller J; Schärer J; Moffa G; Demougin P; Moes S; Stippich C; Falbo S; Neddersen H; Bucher H; Frank S; Jenö P; Lengerke C; Ritz MF; Mariani L; Boulay JL
    Brain Pathol; 2019 May; 29(3):336-350. PubMed ID: 30403311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.
    Toschi L; Finocchiaro G; Nguyen TT; Skokan MC; Giordano L; Gianoncelli L; Perrino M; Siracusano L; Di Tommaso L; Infante M; Alloisio M; Roncalli M; Scorsetti M; Jänne PA; Santoro A; Varella-Garcia M
    PLoS One; 2014; 9(4):e95303. PubMed ID: 24736592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma.
    Iijima Y; Seike M; Noro R; Ibi T; Takeuchi S; Mikami I; Koizumi K; Usuda J; Gemma A
    Int J Oncol; 2015 Feb; 46(2):505-12. PubMed ID: 25384882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
    Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
    Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.
    Woenckhaus J; Steger K; Werner E; Fenic I; Gamerdinger U; Dreyer T; Stahl U
    J Pathol; 2002 Nov; 198(3):335-42. PubMed ID: 12375266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
    Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
    BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.
    Wilbertz T; Wagner P; Petersen K; Stiedl AC; Scheble VJ; Maier S; Reischl M; Mikut R; Altorki NK; Moch H; Fend F; Staebler A; Bass AJ; Meyerson M; Rubin MA; Soltermann A; Lengerke C; Perner S
    Mod Pathol; 2011 Jul; 24(7):944-53. PubMed ID: 21460799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3q26 Amplifications in Cervical Squamous Carcinomas.
    Voutsadakis IA
    Curr Oncol; 2021 Jul; 28(4):2868-2880. PubMed ID: 34436017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and Survival Analysis of Japanese Patients with Resected Non-Small-Cell Lung Cancer Harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA Gene Amplification.
    Inoue Y; Matsuura S; Kurabe N; Kahyo T; Mori H; Kawase A; Karayama M; Inui N; Funai K; Shinmura K; Suda T; Sugimura H
    J Thorac Oncol; 2015 Nov; 10(11):1590-600. PubMed ID: 26536195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
    Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
    PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Holst F; Werner HMJ; Mjøs S; Hoivik EA; Kusonmano K; Wik E; Berg A; Birkeland E; Gibson WJ; Halle MK; Trovik J; Cherniack AD; Kalland KH; Mills GB; Singer CF; Krakstad C; Beroukhim R; Salvesen HB
    Clin Cancer Res; 2019 Jan; 25(1):334-345. PubMed ID: 30442683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of PIK3CA amplification in curatively resected liposarcoma.
    Kim JH; Lee JS; Kim EJ; Park KH; Kim KH; Yi SY; Kim HS; Cho YJ; Shin KH; Ahn JB; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Noh SH; Rha SY; Kim HS
    Oncotarget; 2016 Apr; 7(17):24549-58. PubMed ID: 27016421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer.
    Jehan Z; Bavi P; Sultana M; Abubaker J; Bu R; Hussain A; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Nov; 219(3):337-46. PubMed ID: 19697359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx.
    Liu Y; Dong XL; Tian C; Liu HG
    Diagn Pathol; 2012 Mar; 7():34. PubMed ID: 22463766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic Grading.
    Villaronga MÁ; Hermida-Prado F; Granda-Díaz R; Menéndez ST; Álvarez-Teijeiro S; Quer M; Vilaseca I; Allonca E; Garzón-Arango M; Sanz-Moreno V; Astudillo A; Rodrigo JP; García-Pedrero JM
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):805-813. PubMed ID: 29654156
    [No Abstract]   [Full Text] [Related]  

  • 20. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
    Yang N; Wang Y; Hui L; Li X; Jiang X
    J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.